Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Apr 16;19(4):e0301805. doi: 10.1371/journal.pone.0301805

Dietary total antioxidant capacity of Moroccan Type 2 Diabetes Mellitus patients

Najia El Frakchi 1,2,*, Khaoula El Kinany 2, Marwa El Baldi 2, Younes Saoud 1, Karima El Rhazi 2
Editor: Charles Odilichukwu R Okpala3
PMCID: PMC11020496  PMID: 38625905

Abstract

Aims

A new approach to a healthy diet is the assessment of dietary Total Antioxidant Capacity (TAC). The aim of this study was to assess the dietary TAC among Moroccan Type 2 Diabetes Mellitus (T2DM) patients and identify the main food sources contributing to the total antioxidant capacity intake.

Methods

A total of 254 patients with T2DM was included in the study. The usual dietary intakes were assessed by means of a validated food frequency questionnaire. The dietary TAC was estimated using published databases of the antioxidant content of foods measured by the FRAP (ferric ion reducing antioxidant potential) method.

Results

The mean (SD) dietary TAC of the studied type 2 diabetes patients was 10.86 (3.42) mmol/day. Correlation analyses showed a positive association between dietary TAC and the consumption of healthy food groups, such as fruits and vegetables. Tea and coffee beverages (38.6%), vegetables (21.9%), cereals and pulses (18.8%), fruits and fruit juices (12.4%) were major food sources of dietary antioxidant intake. The relatively short list of twenty food items that contributed most to dietary TAC presented an important explanation of roughly 94%. These included tea, coffee, broad beans, artichoke, pepper, beetroot, sweet potatoes, pomegranate, mandarin, figs, strawberry, orange juice, olives, cashew nuts, almonds, sunflower seeds, dchicha and white beans.

Conclusions

This study supplies baseline dietary TAC data for Moroccan T2DM patients that may help to elucidate which aspects of the eating habits and behaviours require improvement and provide the opportunity to develop dietary guidelines as part of the nutritional diabetes management.

Introduction

Type 2 diabetes mellitus is one of the most frequent chronic diseases worldwide and it is becoming increasingly common non-communicable disease (NCDs) in the Middle East and North Africa (MENA) region. The risk of developing cardiovascular diseases (CVDs) increases linearly with persistent hyperglycemia, favoring the emergence of coronary heart disease, atherosclerosis and other vascular complications [1, 2].

An ample evidence has shown that oxidative damage may contribute to the initiation and progression of diabetes-associated complications [3]. Chronic hyperglycemia triggers multiple metabolic pathways that lead to increased oxidative stress owing to the overproduction of free radicals [4]. Clinical studies have demonstrated accordingly higher concentrations of pro-oxidants and biomarkers of oxidative damage in T2DM patients. It has also been shown that the serum total antioxidant status decreases in T2DM [5, 6]. The low levels of antioxidant enzymes, together with the poor dietary antioxidant intake in comparison to healthy individuals can impair the antioxidant capacity in plasma of this clinical population [7].

Consumption of antioxidant-rich foods in daily diet might be protective against oxidative stress, as substantiated by their effect on increasing antioxidant capacity in the plasma [8]. Since the assessment of single antioxidant intake may not reflect the antioxidant potential of the overall diet and not consider the synergy between dietary antioxidants, a recent nutritional approach of dietary total antioxidant capacity was developed as the cumulative measure of the whole antioxidants present in foods, while considering a synergism that may exist between them [9]. It also can be considered as a predictor of diet quality and plasma antioxidant capacity [10, 11].

The link between improved diet quality and reduced risk of chronic diseases can be partly explained by dietary TAC intake [12]. In this sense, numerous studies have addressed the protective effects of high dietary TAC on metabolic disorders [13, 14]. In some studies, higher dietary TAC was associated with lower risk of hypertension [15], dyslipidemia [16] and reduced risk of incident chronic kidney disease in subjects with hyperglycemia [17]. Furthermore, diets high in TAC showed a negative association with the risk of heart failure, stroke and myocardial infarction in CVDs [1820]. Findings from a prospective cohort studies revealed that high dietary TAC was associated with a lower risk of mortality from all causes, cancer, and CVDs [21, 22].

Morocco is known as a southern Mediterranean Sea country, and the subregion of Tetouan, located in the extreme north of Morocco, represents an interesting example of a fortified city on the Mediterranean coast. Its strategic position across the Gibraltar Gulf has made it an important crossroads between two civilizations (Spanish and Arab) and two continents (Europe and North Africa). Culturally, the typical eating habits are based on cereals, mainly soft wheat. This has increasingly substituted the traditional cereals of durum wheat and barley, particularly in the preparation of bread. Fruits and vegetables figure greatly in the diet and includes mainly citrus fruits (oranges, clementines, mandarins), apples, pears, grapes, tomatoes and tuberous vegetables. Potatoes also take an important part in the diet. The dietary pattern is also characterized by a large intake of pulses such as lentils, chickpeas, dried peas and broad beans and a greater use of olive oil. Tea still a widely consumed beverage [23]. Nonetheless, the nutritional transition towards westernised diet is in progress [24, 25].

Understanding dietary intake of antioxidants has an important interest, particularly in clinical populations with underlying oxidative stress and inflammatory injuries. The aim of this study is therefore to assess the daily dietary antioxidant capacity of T2DM patients and identify the top food contributors commonly eaten in Morocco.

Methods

Schematic overview of field questionnaire study

The study procedure advocates data collection in three stages (STEP) (Fig 1). The first Step consists of a face-to-face interview to collect demographic data and behavioral risk factors via a questionnaire. The second Step concerns the anthropometric parameter measurements using standard methods. The final Step includes dietary data assessment using a validated S-FFQ during a face-to-face interview by trained dietitian. This approach allows assessing dietary TAC, exploring the association between dietary TAC and the characteristics of diabetic study participants as well as identifying the major common food contributors to the antioxidant potential of the diet. This investigation may help to underline which aspects of the eating behaviors of this clinical population require improvement in order to enhance their dietary TAC and then ensuring a quality diet.

Fig 1. Study procedure flow diagram.

Fig 1

Study participants

This cross-sectional study was carried out in Tetouan, a city in the north of Morocco, from February 2021 to July 2022 among type 2 diabetes outpatients using convenience-sampling method. The patients were enrolled from primary public health care centers and Clinical Department of Endocrinology, Diabetology at Provincial Hospital of Tetouan.

The inclusion criteria were adult patients with pathologically confirmed type 2 diabetes for at least one year and having completed data in dietary intake and confounding variables. Patients were excluded if they were pregnant, had type 1 diabetes, gestational diabetes, related disorders interfering with cognition or compliance, imperfect demographic or anthropometric information and who had missing data on dietary record. In total, a sample of 254 T2DM patients aged 34–76 years was examined in the present study.

We should highlight that the majority of diabetes patients were women. This finding is supported by previous studies which reported that T2DM is a predominant disease in women [26, 27]. Additionally, the National Family Health Survey assumes that a female gender presents a prominent risk group [28].

Participation was voluntary, and informed written consents were required from all participants. The study protocol was approved by the ethical committee of the University Hospital Center of Fez (ref. n° 06/20).

Demographic data

A face-to-face interview was carried out to collect information on sociodemographic and lifestyle features such as age, sex, marital status, educational level, occupation and physical activity using an epidemiological questionnaire. It was based on the STEPS instrument developed by the World Health Organization (WHO) according to the STEPwise approach for chronic disease survey and which was also used in the National Survey on Common Risk Factors for NCDs [29, 30].

Educational level was classified as "illiterates", "≤ 6 years of schooling" (primary, informal or koranic education), and "> 6 years of schooling "(secondary, university level). Two categories of the marital status were included: married and singles, while "singles" were widowed, unmarried and divorced. Occupation activity was recorded into two classes: "worker" and "retired or unemployed or housekeeper".

Physical activity level was assessed with the version translated to Arabic of Global Physical Activity Questionnaire (GPAQ) [31]. Data on physical activity were analysed according to the GPAQ Analysis Guide [32] and the metabolic equivalent task (MET) value was computed. Physical activity level was categorised as low (< 600 MET-minutes per week), moderate (600–3000 MET-minutes per week) and high level (≥ 3000 MET-minutes per week) [33].

Clinical measurements

The clinical measurements were performed by healthcare personnel according to the standardized procedures [34]. Body weight was measured with a calibrated electronic scale in minimal clothing and without shoes. Standing height without shoes was also obtained using a mural stadiometer. Body mass index (BMI) was calculated as weight in kilograms divided by the square of the height in meters [35]. Systolic and diastolic blood pressure was measured using an automatic Omron tensiometer for three times and the mean of the last two blood pressure measurements was considered in the analyses. Arterial hypertension in the studied diabetes patients was defined as taking antihypertensive medication or systolic blood pressure ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg [36].

Dietary intake assessment

The usual dietary intake of the studied diabetes patients was assessed using a validated semi-quantitative food frequency questionnaire (FFQ) with 255 food items, which was done face-to-face by trained dietitian. As previously described [37], this FFQ has shown a good relative validity compared to the dietary average obtained from three 24-hour recalls and there were no sex differences regarding the reliability of reported dietary intakes. The questionnaire was validated for use in Moroccan population and was designed to obtain data on usual food intake during the previous year. Food consumption for each item was questioned based on a daily, weekly, or monthly frequency versus portion size. The reported frequency was then converted to the amount of each several consumed food items in grams per day. Energy and nutrient intakes of consumed foods were calculated using the food composition tables from Tunisia [38] and Morocco [39].

Assessment of dietary TAC

Dietary TAC was estimated using a previously published database with the total amount of antioxidant capacity expressed as mmol per 100 g of over 3100 types of foods and beverages from different countries [40, 41], obtained according to ferric-reducing antioxidant power (FRAP) method [42]. The dietary antioxidant capacity was estimated by multiplying the daily intake of foods and beverages by their related antioxidant content. Thus, the dietary TAC is a sum of all TAC values from each food item consumed, in mmol per day. For foods for which TAC values were not available on the database, the value of the closest comparable foodstuff was used as a proxy: for bakkoula (Moroccan salad recipe based on leaves similar to spinach) the TAC value for spinach has been used; for dchicha (traditional Moroccan soup based on barley semolina) and saykouk (Moroccan dish made from barley couscous and buttermilk), the estimated TAC for the barley was used. For cooked foods with missing FRAP values, the value of the fresh food was considered. Finally, the dietary TAC estimate was classified into three groups (tertiles). The first and third tertiles had the lowest and highest dietary TAC scores, respectively.

Statistical methods

The SPSS Statistics for Windows, version 25.0 was used to perform the Statistical analyses. The normality of variables was tested using the Kolmogorov-Smirnov test. Continuous variables were presented as means ± standard deviation and categorical variables were presented as numbers and percentages. Variables were categorized by tertiles of dietary TAC. The chi-square test was used to compare categorical data, and the analysis of variance (ANOVA) or the Kruskal-Wallis test was used to compare continuous data.

Correlation analyses between dietary TAC and dietary variables with normal and non-normal distribution were done respectively by the Pearson and Spearman test.

The contribution of different food groups to the total dietary antioxidant intake was computed as the ratio of the antioxidant capacity provided by the corresponding food group to the dietary TAC estimate from all foods.

To assess the explanatory ability of various foods and beverage items on FRAP levels; we used stepwise multiple regression analysis. A p for entry into the regression model of < 0.05 and a p for removal of > 0.10 were used. We first ran separate models within each food group (vegetables, cereals, fruits, legumes, dairy product, oils, nuts and beverage) to identify which food items that best explained the dietary antioxidant variation within a food group. In the final model, we included all the individual food items obtained from the preceding analysis. We report both the standardized and the unstandardized regression coefficients. To select the top food predictors, the list of the food items was figured in descending order according to the beta values.

All reported p-values are based on two-tailed hypotheses and p-values < 0.05 were regarded significant.

Results

Estimated daily dietary TAC

The mean (SD) dietary antioxidant capacity was 10.86 (3.42) mmol/day, and the mean energy intake was 2561.9 (643.7) kcal/day.

The general characteristics of participants by FRAP indices tertiles are displayed in Table 1. The majority of diabetes patients were women and from urban areas. The mean (SD) of age was 54.52 (7.21) years old and the mean (SD) diabetes duration was 8.2 (6.4) years. The prevalence of overweight and obesity was, respectively, 39.8% and 47.2%, while arterial hypertension prevailed in 70% of the studied diabetes patients.

Table 1. General characteristics of T2DM patients according to tertiles of dietary TAC.

Variables All Dietary Total Antioxidant Capacity p- value
T1 (lowest) T2 T3 (highest)
(n = 85) (n = 84) (n = 85)
Gender, 0.609
Woman, n (%) 219(86.2) 72(84.7) 75(89.3) 72(84.7)
Age (years), Mean ± SD 54.52 ± 7.21 55.73 ± 6.17 54.32 ± 8.09 53.49 ± 7.14 0.036
Marital status, n (%) 0.969
Married 207(81.5) 70(82.4) 68(81) 69(81.2)
Singles 47(18.5) 15(17.6) 16(19) 16(18.8)
Occupation, n (%) 0.208
Worker 53(20.9) 14(16.5) 16(19) 23(27.1)
Retired or unemployed or house keeper 201(79.1) 71(83.5) 68(81) 62(72.9)
Residency 0.311
Urban, n (%) 237(93.3) 77(90.6) 81(96.4) 79(92.9)
Monthly household income, n (%) 0.094
< 3000 MAD 210(82.7) 77(91.7) 69(83.1) 64(80)
> 3000 MAD 37(14.6) 7(8.3) 14(16.9) 16(20)
Educational level, n (%) 0.912
Illiterate 117(46.1) 41(48.2) 39(46.4) 37(43.5)
≤ 6 years 98(38.6) 30(35.3) 34(40.5) 34(40)
> 6 years 39(15.4) 14(16.5) 11(13.1) 14(16.5)
Diabetes duration (years), 8.2 ± 6.4 7.2 ± 7.1 8.2 ± 5.7 9.1 ± 6.1 0.018
Mean ± SD
Medication use, n (%) 0.122
Oral Antidiabetic Drugs 176(69.3) 60(70.6) 65(77.4) 51(60)
Insulin 51(20.1) 14(16.5) 15(17.9) 22(25.9)
Oral Antidiabetic Drugs + Insulin 19(7.5) 8(9.4) 4(4.8) 7(8.2)
Hypertension, n (%) 177(70) 66(77.6) 54(65.1) 57(67.1) 0.16
Dyslipidemia, n (%) 90(35.4) 28(32.9) 31(36.9) 31(36.5) 0.839
Physical activity, n (%) 0.175
Low 77(30.3) 33(38.8) 24(28.6) 20(23.5)
Moderate 66(26.0) 23(27.1) 20(23.8) 23(27.1)
High 111(43.7) 29(34.1) 40(47.6) 42(49.4)
Physical activity. METs-h per week 50.49 ± 46.72 39.7 ± 36.2 50.4 ± 39.5 61.2 ± 58.9 0.010
Body mass index (kg/m2), n (%) 0.157
Normal 33(13.0) 7(8.2) 9(10.7) 17(20)
Overweight (25–30) 101(39.8) 33(38.8) 34(40.5) 34(40)
Obesity (≥30) 120(47.2) 45(52.9) 41(48.8) 34(40)
Blood pressure (mmHg), Mean ± SD
Systolic Blood pressure 140.75 ± 20.01 145.87 ± 19.10 139.82 ± 20.69 136.57 ± 19.31 0.008
Diastolic Blood pressure 80.53 ± 11.23 81.98 ± 12.72 80.36 ± 10.20 79.22 ± 10.55 0.36

Continuous variables are presented as mean ± SD, while categorical variables are presented as number of the participants (percentages).

p -value is for ANOVA or Kruskal-Wallis test for continuous variables and Chi-square test for a categorical variable, p < 0.05 was considered as statistically significant.

MAD Moroccan Dirham, MET, metabolic equivalent task

As can be seen, participants with a higher dietary antioxidant capacity had significantly a lower age (p = 0.036), higher diabetes duration (p = 0.018), lower systolic blood pressure level (p = 0.008), and were more likely to be physically active than those with lower values of TAC (p = 0.01). No significant differences were found for the remaining variables.

Dietary intake according to dietary antioxidant capacity level

Nutrient and food intakes across tertiles of the energy-adjusted dietary TAC of patients with T2DM are presented in Table 2. In comparison with the participants assigned to the lowest tertile, those in the highest tertile of the dietary TAC had significantly higher intakes of carbohydrate (p = 0.012), total protein (p = 0.009), polyunsaturated fatty acid (p = 0.041), dietary fiber (p = 0.002), calcium (p < 0.001), magnesium (p < 0.001), iron (p = 0.022), folic acid (p < 0.001), thiamin (p < 0.001), riboflavin (p < 0.001), niacin (p = 0.003), vitamin B6 (p = 0.003), and some nutrients with antioxidant potential, including vitamin A (p = 0.028), vitamin C (p = 0.002), β-carotene (p = 0.029), and zinc intakes (p < 0.001).

Table 2. Dietary characteristics according to the tertiles of dietary TAC of T2DM patients.

Dietary total antioxidant capacity
Coefficient correlation T1 T2 T3 p
(r) (< 9.84) (9.84–12.24) (> 12.24)
Nutrients intake
Carbohydrate (g/day) 0.004 312.43 ± 100.0 346.6 ± 88.9 312.45 ± 82.26 0.012
Protein (g/day) 0.039 84.2 ± 25.5 95.5 ± 24.8 87.6 ± 22.4 0.009
Total fat (g/day) − 0.030 109.2 ± 39.7 117.7 ± 39.9 115.9 ± 37.7 0.334
SFA e (g/day) 0.008 19.3 ± 8.5 21.1 ± 7.3 19.7 ± 7.1 0.090
MUFA c (g/day) 0.008 52.4 ± 19.3 55.6 ± 21.3 56.1 ± 20.2 0.398
PUFA d (g/day) 0.011 17.7 ± 6.3 19.8 ± 6.5 18.0 ± 5.7 0.041
Fiber (g/day) 0.109 46.7 ± 19.2 56.4 ± 20.8 50.4 ± 18.5 0.002
Folic acid (mcg/day) 0.192 a 880.1 ± 346.0 1199.5 ± 506.6 1164.1 ± 439.4 < 0.001
Vitamin A (mcg/day) 0.105 479.3 ± 214.0 591.6 ± 299.8 555.0 ± 258.5 0.028
Vitamin E (mg/day) 0.070 20.2 ± 7.6 22.8 ± 8.4 22.2 ± 7.4 0.050
Vitamin C (mg/day) 0.212 b 86.9 ± 42.7 100.6 ± 44.0 112.1 ± 55.5 0.002
Vitamin D (mcg/day) 0.062 6.3 ± 3.2 6.8 ± 3.2 7.0 ± 3.4 0.473
Vitamin B6 (mg/day) 0.117 57.0 ± 88.4 83.7 ± 116.1 61.0 ± 68.8 0.003
Vitamin B12 (mcg/day) 0.079 40.1 ± 36.1 41.3 ± 39.5 46.2 ± 36.7 0.292
Riboflavin (mg/day) 0.204 b 2.2 ± 0.6 2.7 ± 0.7 2.6 ± 0.7 < 0.001
Niacin (mg/day) 0.096 23.6 ± 6.2 27.0 ± 6.1 25.9 ± 6.7 0.003
Thiamin (mg/day) 0.141a 2.4 ± 0.6 2.9 ± 0.8 2.8 ± 0.8 < 0.001
β-carotene (mcg/day) 0.119 3253.8 ± 2424.3 4152.7 ± 2449.0 4030.4 ± 2924.5 0.029
Magnesium (mg / day) 0.284 b 541.1 ± 173.3 705.3 ± 242.3 708.2± 234.8 < 0.001
Calcium (mg/day) 0.204 b 623.2 ± 203.8 767.7 ± 274.5 774.6 ± 264.1 < 0.001
Iron (mg/day) 0.129 b 49.9 ± 41.6 62.2 ± 47.3 72.7 ± 65.9 0.022
Zinc (mg/day) 0.157 b 25.2 ± 16.6 34.6 ± 21.6 30.4 ± 14.5 < 0.001
Selenium (mcg/day) 0.007 129.2 ± 35.6 139.6 ± 32.3 132.5 ± 35.6 0.126
Food intakes. g/day
Vegetables 0.335 b 225.0 ± 97.9 340.6 ± 154.4 362.5 ± 164.5 < 0.001
Potatoes − 0.008 71.1 ± 57.7 75.8 ± 43.8 68.3 ± 53.0 0.074
Legumes − 0.060 126.7 ± 94.5 153.1 ± 120.8 118.7 ± 89.2 0.146
Cereals − 0.085 388.0 ± 115.8 407.5 ± 97.9 368.7 ± 107.9 0.064
Whole grain cereals 0.091 180.4± 169.5 196.1 ± 171.2 207.2 ± 156.2 0.406
Refined grain cereals − 0.130 b 209.2 ± 164.4 218.3 ± 165.0 168.1 ± 141.2 0.133
Fruits 0.159 b 187.6 ± 129.2 196.0 ± 109.0 231.9 ± 132.0 0.041
Fruit juices 0.093 31.2 ± 44.8 40.8 ± 51.6 43.2 ± 70.2 0.332
Dairy and dairy products 0.015 86.0 ± 72.6 105.4 ± 94.7 105.4 ± 115.9 0.537
Red meat − 0.100 17.01 ± 18.66 17.06 ± 19.18 13.46 ± 16.29 0.37
Poultry − 0.049 30.3 ± 23.5 31.1 ± 21.1 28.6 ± 19.8 0.77
Eggs − 0.064 16.8 ± 12.7 21.0 ± 25.6 15.7 ± 13.3 0.56
Fish 0.098 45.1 ± 25.9 48.3 ± 25.0 53.6 ± 27.7 0.16
Tea 0.465 b 97.1 ± 84.4 163.5 ± 115.4 274.2 ± 186.2 < 0.001
Coffee 0.217 b 63.1 ± 57.6 88.9 ± 78.9 127.3 ± 131.1 0.012
Nuts and seeds 0.117 1.6 ± 3.2 4.0 ± 7.1 4.6 ± 11.0 0.168
Fats and Oils − 0.028 49.1 ± 22.1 49.1 ± 24.4 50.2 ± 22.7 0.829

Adjusted for Energy intake by residual method. T, tertile. TAC (mmol/day) Mean (SD) minimum—maximum: T1 (8.15 [1.19], 5.59–9.83); T2 (10.94 [0.72], 9.84–12.24); T3 (14.68 [2.06], 12.25–20.96).

p—values is for ANOVA for continuous variables with normal distribution or Kruskal-Wallis test for continuous variables without normal distribution

a p -value <0.05 according to Pearson’s Correlation test (r),

b p -value <0.05 according to Spearman’s Correlation test (r)

Data are expressed as means ± standard deviations, p <0.05 was considered as statistically significant.

c MUFA, monounsaturated fatty acid;

d PUFA, polyunsaturated fatty acid;

e SFA, saturated fatty acid

In addition, participants in the highest tertile of dietary TAC had higher consumption of vegetables (p < 0.001), fruits (p = 0.041), tea (p < 0.001) and coffee (p = 0.012), than those included in the lowest tertile. No other significant differences were found in food and nutrient intakes across tertiles of energy-adjusted dietary TAC.

As observed in correlation analysis in Table 2, dietary TAC showed a statistically significant positive correlation with the estimate intakes of vitamin C (r = 0.212; p = 0.001), thiamin (r = 0.141; p = 0.025), riboflavin (r = 0.204; p = 0.001), folic acid (r = 0.192; p = 0.002), magnesium (r = 0.284; p <0.001), calcium (r = 0.204; p = 0.001), iron (r = 0.129; p = 0.041), zinc (r = 0.157; p = 0.012) and the consumption of vegetables (r = 0.335; p < 0.001), fruits (r = 0.159; p = 0.011), tea and coffee beverages (r = 0.465, r = 0.217; respectively; p < 0.001). However, there was a negative correlation between the dietary TAC and the consumption of refined grain cereals (r = − 0.13, p = 0.038).

Major food sources contributing to the dietary antioxidants

The main food groups that contributed to the dietary antioxidant capacity intake were tea and coffee beverages (38.6%), vegetables (21.9%), cereals and pulses (18.8%), fruits and fruit juices (12.4%). The other food categories, such as potatoes, nuts and seeds, fish, dairy products, meats and olive oil, contributed altogether only to around 7% of antioxidants intake (Fig 2).

Fig 2. Major food sources of dietary TAC of Moroccan T2DM patients.

Fig 2

To identify the contribution of each food item consumed to the dietary TAC variation of the diabetes patient’s diet, all the several individual food categories were forced into the stepwise multiple regressions with dietary TAC as further described. The regression coefficients from the final model was presented in Table 3. The top twenty food items predicting the dietary antioxidant intake were listed according to the decreasing impact. These foods were tea and coffee beverages, broad beans, artichoke, almonds, orange juice, dchicha (traditional Moroccan soup based on barley semolina), pomegranate, olives, mandarin, pepper, sweet potatoes, beetroot, sunflower seeds, white beans, strawberry, figs and cashew nuts. These 20 food items explained 94% of the total antioxidant intake variation. When we reran the model with excluding tea and coffee contribution, the rest of the selected food items remain as important explanatory of roughly 54%.

Table 3. Regression coefficients of top 20 food items contributing to antioxidant intake in T2DM patients.

Rank Food items* (g/day) Unstandardized coefficients Standardized coefficients
Estimate Std. error Estimate p- value
1 Tea, green, prepared 0.01 < 0.001 0.63 < 0.001
2 coffee, liquid 0.02 0.001 0.49 < 0.001
3 Broad beans, green 0.02 0.001 0.39 < 0.001
4 Coffee, instant, prepared 0.02 0.001 0.19 < 0.001
5 Black tea, infusion 0.01 0.001 0.19 < 0.001
6 Artichoke, boiled 0.06 < 0.01 0.14 < 0.001
7 Almonds 0.16 0.02 0.13 < 0.001
8 Orange juice < 0.01 0.001 0.12 < 0.001
9 Dchicha 0.02 < 0.01 0.12 < 0.001
10 Pomegranate 0.02 < 0.01 0.11 < 0.001
11 Olives 0.01 < 0.01 0.10 < 0.001
12 Mandarin 0.02 < 0.01 0.08 < 0.001
13 Pepper 0.02 < 0.01 0.07 < 0.001
14 Sweet potatoes 0.01 < 0.01 0.07 < 0.001
15 Beetroot 0.03 < 0.01 0.06 < 0.001
16 Sunflower seeds 0.06 0.02 0.06 < 0.001
17 White beans < 0.01 0.001 0.06 < 0.001
18 Strawberry 0.04 0.01 0.04 0.01
19 Figs 0.02 < 0.01 0.04 0.02
20 Cashew nuts 0.22 0.10 0.04 0.03

* Ranked in descending order according to standardized beta coefficients.

Discussion

In the present study, we assessed the dietary TAC in T2DM patients. The food sources that contributed most to the total antioxidant capacity intake were also identified. Up to our knowledge, this is the first attempt to explore dietary antioxidant index levels among Moroccans. Nonetheless, the adherence to a Mediterranean dietary pattern was widely assessed [43, 44].

The estimated dietary TAC of Moroccan patients with type 2 diabetes using the FRAP method was 10.86 mmol/day. This finding is in accordance with TAC of 10.62 mmol/day in patients with metabolic syndrome from Spain [45], the TAC of 11.86 mmol/day in adults with prediabetes from Persian country [46] and to the TAC of 10.84 mmol/day in patients with cardiovascular disease [47]. Meanwhile, some observational studies showed that consumption of dietary TAC approximately ≥ 13.48 mmol/d based on the FRAP assay was associated with lower risk of cardiovascular disease [48]. Findings from a meta-analysis of prospective cohort studies have shown that a 5 mmol/day increase in dietary TAC, based on the FRAP method, was associated with a 7% lower risk of all-cause mortality [21].

As regards the distribution of descriptive features of diabetes patients by dietary TAC (Table 1), the finding that diabetic patients with low physical activity behavior and high blood pressure level consumed a diet with a lower antioxidant potential, could be a serious health concern. Physical inactivity and elevated blood pressure are common risk factors associated with CVDs in diabetes patients. Therefore, in these specific conditions, a greater average of antioxidant intake is recommended since the increased demand. In addition, it was found that diabetes patients in the highest tertile of dietary TAC had a greater intake of dietary fibre and higher consumption of plant-based foods such as fruits and vegetables than those in the lowest tertile (Table 2). The benefits of high fiber diet in T2DM has been long appreciated. A high intake of dietary fibre will benefit the metabolic health in patient with T2DM [49]. An inverse relationship between total dietary fiber intake and the risk of developing CVDs has been also evidenced [50].

Some authors suggest that dietary TAC may be considered an appropriate measure of diet quality because it positively correlates with well-known indicators of a healthy diet [51]. Those indicators approve mutually high intake of healthy foods such as fruits and vegetables, which provide a good source of antioxidants, and then contribute to the antioxidant potential of the diet. Our study supported this association, showing a positive relationship between dietary FRAP and the consumption of vegetables and fruits as well (Table 2).

A strong correlation has been found between dietary TAC and plasma antioxidant capacity [11], suggesting that dietary antioxidant capacity might be investigated as a measurement of antioxidant intakes. The present study showed a significant positive association between dietary TAC and dietary intake of vitamin C, folic acid, iron, magnesium and zinc (Table 2), in agreement with previous findings [14, 52].

There is a wide divergence between countries regarding food contribution to the dietary TAC intake. The main contributors to the dietary antioxidant capacity in Greek population were fruits (45.5%), vegetables (38.8%), dry fruits (31.1%), cereals (28%) and nuts (26.1%) [53]. In Spanish population, there was coffee (43.7%), fruits (26.2%) followed by vegetables [54]. The Major contributors to dietary FRAP in French women were fruits (23%), vegetables (19%), alcoholic beverages (15%) and hot beverages such as tea and hot chocolate (12%) [55]. The major foods in Italian population were coffee, alcoholic beverages, fruit and fruit juices [56]. In the Polish population with cardiovascular disease, there were tea and coffee beverages, vegetables, fruits and cereal products [57]. The food groups that contributed most to dietary FRAP in the Rotterdam population were coffee, fruit, vegetables and tea [58]. The main contributors to the dietary TAC in the Turkish population were beverages, vegetables, legumes/nuts and fruits [59]. In our study, the highest contributors to dietary TAC estimate were tea and coffee beverages, vegetables, fruits, cereals and pulses (Fig 2). As expected, coffee and tea drinks stood out as the major contributor to dietary antioxidant both due to their high antioxidant level and their consumption by a large part of the study population. The group of fruits and vegetables was the second that most contributed to the determination of dietary antioxidant capacity in the studied diabetes patients. Despite the fact that these foods are nutrient-rich and antioxidant- abundant, it may also be partially explained by the appropriate rate of fruit and vegetable consumption. The mean daily consumption of vegetables (without potatoes) and fruits estimated was 309.6 g and 214.7g, respectively, values well as recommended by the WHO [60].

There will often be a significant difference in which food explains the total intake, and which explain the between person variation. Identifying the dietary factors contributing to the dietary antioxidant variation is more important for research in the epidemiology of diseases. Whereas, assessing the foods that contribute to total antioxidant intake can be useful for clinical nutrition, which aims to focus on good sources with high antioxidant capacities and commonly eaten in order to improve the antioxidant capacity in the patient’s diet. Therefore, this study also addressed capturing the antioxidant intake variation (Table 3). Coffee and tea drinks were found to have the greatest impact on the dietary TAC. Fruits and vegetables also contributed significantly to the variation. Among vegetables, the most important item was broad beans and among fruits, it was the pomegranate. However, when we removed the tea and coffee beverages from the list of top 20 food items explaining most the antioxidant intake variation, the remaining fruit and vegetable foodstuffs contributed 48.6%. In other words, compared to the contribution of coffee and tea, fruits and vegetables explain in the same extent of around 49% the between person variation in antioxidant intake.

The current study has some limitations. The dietary TAC determination was based on an international database, in which the values may vary in relation to the food produced in Morocco. Therefore, we selected database that reported total antioxidant content of large food items consumed worldwide and which contained most of the foods that are commonly consumed by the Moroccan population. The strength of this study is that it is the first attempt to assess the total antioxidant potential of antioxidants consumed in the whole diet by the concept of dietary TAC index among Moroccan patients with T2DM. Furthermore, the data collection was performed by qualified nutritionist, and the questionnaire used, even though is prone to measurement error, it was detailed and validated for use in the Moroccan adult population, then capturing most of the antioxidant-rich foods.

Conclusion

In summary, the estimate of the dietary TAC of Moroccan patients with T2DM was found closely comparable to that of the population of Mediterranean countries and those with similar metabolic disorders. Nonetheless, dietary TAC intake in this clinical population needs to be further improved. Tea, coffee, vegetables, fruits and cereals were the major food sources of antioxidant capacity of the diet. Whereas, despite the tea and coffee beverages, broad beans, artichoke, pomegranate, orange juice, almonds, dchicha, olives and mandarin were among the major foods contributing in dietary TAC. Therefore, consumption of these foods may be a good strategy to increase dietary TAC. This study supplies baseline dietary TAC data among Moroccan T2DM patients, which will be useful in developing dietary recommendations as part of the nutritional management of diabetes. Further investigation of the health contribution of dietary antioxidant capacity in diabetes outcome in Morocco is warranted.

Acknowledgments

The authors appreciate the cooperation of the diabetes patients in this work.

Data Availability

All relevant data are within the manuscript.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Fowler MJ. Microvascular and Macrovascular Complications of Diabetes. Clin Diabetes. 2008;77–82. doi: 10.2337/diaclin.26.2.77 [DOI] [Google Scholar]
  • 2.Vehkavaara S, Seppälä-Lindroos A, Westerbacka J, Groop PH YJ H. In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care. 1999;2055–60. doi: 10.2337/diacare.22.12.2055 [DOI] [PubMed] [Google Scholar]
  • 3.Bandeira S de M, da Fonseca LJS, Guedes G da S, Rabelo LA, Goulart MOF, Vasconcelos SML. Oxidative stress as an underlying contributor in the development of chronic complications in diabetes mellitus. Int J Mol Sci. 2013;14(2):3265–3284. doi: 10.3390/ijms14023265 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Fiorentino TV, Prioletta A, Zuo P FF. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des. 2013;19(32):5695–703. doi: 10.2174/1381612811319320005 [DOI] [PubMed] [Google Scholar]
  • 5.Ganjifrockwala FA, Joseph JT, George G. Decreased total antioxidant levels and increased oxidative stress in South African type 2 diabetes mellitus patients. J Endocrinol Metab Diabetes South Africa [Internet]. 2017;22(2):21–25. Available from: doi: http%3A//doi.org/10.1080/16089677.2017.1324590 [Google Scholar]
  • 6.Singla H, Goyal G, Garg C, Bhalla K. Total antioxidant status in type 2 diabetes mellitus with diabetic nephropathy. Int J Adv Med. 2019;6(3):673. doi: 10.18203/2349-3933.ijam20191540 [DOI] [Google Scholar]
  • 7.Zujko ME, Witkowska AM, Górska M, Wilk J, Kretowski A. Reduced intake of dietary antioxidants can impair antioxidant status in type 2 diabetes patients. Pol Arch Med Wewn. 2014;124(11):599–607. doi: 10.20452/pamw.2497 [DOI] [PubMed] [Google Scholar]
  • 8.Ávila-Escalante ML, Coop-Gamas F, Cervantes-Rodríguez M, Méndez-Iturbide D, Aranda-González II. The effect of diet on oxidative stress and metabolic diseases—Clinically controlled trials. J Food Biochem. 2020;44(5):1–16. doi: 10.1111/jfbc.13191 [DOI] [PubMed] [Google Scholar]
  • 9.Puchau B, Zulet MÁ, de Echávarri AG, Hermsdorff HHM, Martínez JA. Dietary total antioxidant capacity: A novel indicator of diet quality in healthy young adults. J Am Coll Nutr. 2009;28(6):648–656. doi: 10.1080/07315724.2009.10719797 [DOI] [PubMed] [Google Scholar]
  • 10.Salari-Moghaddam A, Nouri-Majd S, Keshteli AH, Emami F, Esmaillzadeh A, Adibi P. Association Between Dietary Total Antioxidant Capacity and Diet Quality in Adults. Front Nutr. 2022;9(April):1–7. doi: 10.3389/fnut.2022.838752 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Carrión-García CJ, Guerra-Hernández EJ, García-Villanova B, Serafini M, Sánchez MJ, Amiano P, et al. Plasma non-enzymatic antioxidant capacity (NEAC) in relation to dietary NEAC, nutrient antioxidants and inflammation-related biomarkers. Antioxidants. 2020;9(4) doi: 10.3390/antiox9040301 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chiuve SE, Sampson L, Willett WC. The Association Between a Nutritional Quality Index and Risk of Chronic Disease. AMEPRE [Internet]. 2011;40(5):505–13. Available from: doi: 10.1016/j.amepre.2010.11.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Zujko Małgorzata ElżMałgorzata Elżbieta, bieta Z Waśkiewicz Anna, Maria Witkowska Anna, Szcześniewska Danuta, Zdrojewski Tomasz, Kozakiewicz Krystyna D W. Dietary Total Antioxidant Capacity and Dietary Polyphenol Intake and Prevalence of Metabolic Syndrome in Polish Adults: A Nationwide Study. Oxid Med Cell Longev. 2018;10 pages. doi: 10.1155/2018/7487816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Puchau B, Zulet MA, de Echávarri AG, Hermsdorff HH M J. Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition. 2010;26:26(5):534–41. doi: 10.1016/j.nut.2009.06.017 [DOI] [PubMed] [Google Scholar]
  • 15.Fateh HL, Mirzaei N, Gubari MIM, Darbandi M, Najafi F, Pasdar Y. Association between dietary total antioxidant capacity and hypertension in Iranian Kurdish women. BMC Womens Health. 2022;22(1):1–7. doi: 10.1186/s12905-022-01837-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kim SA, Joung H, Shin S. Dietary pattern, dietary total antioxidant capacity, and dyslipidemia in Korean adults. Nutr J. 2019;18(1):1–12. doi: 10.1186/s12937-019-0459-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Asghari G, Yuzbashian E, Shahemi S, Gaeini Z, Mirmiran P, Azizi F. Dietary total antioxidant capacity and incidence of chronic kidney disease in subjects with dysglycemia: Tehran Lipid and Glucose Study. Eur J Nutr. 2018;57(7):2377–2385. doi: 10.1007/s00394-017-1511-2 [DOI] [PubMed] [Google Scholar]
  • 18.Rautiainen S, Levitan EB, Mittleman MA, Wolk A. Total antioxidant capacity of diet and risk of heart failure: A population-based prospective cohort of women. Am J Med [Internet]. 2013;126(6):494–500. Available from: doi: 10.1016/j.amjmed.2013.01.006 [DOI] [PubMed] [Google Scholar]
  • 19.Milajerdi A, Shakeri F, Keshteli AH, Mousavi SM, Benisi-Kohansal S, Saadatnia M, et al. Dietary total antioxidant capacity in relation to stroke among Iranian adults. Nutr Neurosci [Internet]. 2019;0(0):1–6. Available from: doi: 10.1080/1028415X.2018.1520478 [DOI] [PubMed] [Google Scholar]
  • 20.Hantikainen E, Löf M, Grotta A, Trolle Lagerros Y, Serafini M, Bellocco R, et al. Dietary non enzymatic antioxidant capacity and the risk of myocardial infarction in the Swedish women’s lifestyle and health cohort. Eur J Epidemiol. 2018;33(2):213–221. doi: 10.1007/s10654-018-0361-4 [DOI] [PubMed] [Google Scholar]
  • 21.Parohan M, Anjom-Shoae J, Nasiri M, Khodadost M, Khatibi SR, Sadeghi O. Dietary total antioxidant capacity and mortality from all causes, cardiovascular disease and cancer: a systematic review and dose—response meta-analysis of prospective cohort studies. Eur J Nutr [Internet]. 2019;58(6):2175–2189. Available from: doi: 10.1007/s00394-019-01922-9 [DOI] [PubMed] [Google Scholar]
  • 22.Ha K, Kim K, Sakaki JR, Chun OK. Relative validity of dietary total antioxidant capacity for predicting all-cause mortality in comparison to diet quality indexes in us adults. Nutrients. 2020;12(5). doi: 10.3390/nu12051210 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.FAO. Profil Nutritionnel du Maroc—Division de la nutri- tion et de la protection des consommateurs. http://www.fao.org/3/a-bc635 f.pdf.
  • 24.B R. Nutrition transition and food sustainability. Proc Nutr Soc. 2014;385–8. doi: 10.1017/S0029665114000135 [DOI] [PubMed] [Google Scholar]
  • 25.Allali F. Nutrition transition in Morocco. Integr J Med Sci. 2017;4(1):70–73. [Google Scholar]
  • 26.Sobers-Grannum N, Murphy MM, Nielsen A, Guell C, Samuels TA, Bishop LUN. Female gender is a social determinant of diabetes in the Caribbean: a systematic review and meta-analysis. PLoS One. 2015;10(5):e0126799. doi: 10.1371/journal.pone.0126799 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Barich F, Zahrou FE, Laamiri FZ, El Mir N, Rjimati M, Barkat A, et al. Association of Obesity and Socioeconomic Status among Women of Childbearing Age Living in Urban Area of Morocco. J Nutr Metab. 2018;2003–2004. doi: 10.1155/2018/6043042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ministére de la Santé. Enquête nationale sur la population et la santé familiale 2011-Indicateurs régionaux.
  • 29.WHO. The STEPS Instrument and Support Materials. Geneva: World Health Organization. 2016;1–15. http://www.who.int/chp/steps/. [Google Scholar]
  • 30.Ministére de la Santé. RAPPORT DE L’ENQUÊTE NATIONALE SUR LES FACTEURS DE RISQUE COMMUNS DES MALADIE NON TRANSMISSIBLES, STEPS, 2017–2018 https://www.sante.gov.ma.
  • 31.Doyle C, Khan A BN. Reliability and validity of a self-administered Arabic version of the Global Physical Activity Questionnaire (GPAQ-A). J Sport Med Phys Fitness. 2019;59(7):1221–1228. doi: 10.23736/S0022-4707.18.09186-7 [DOI] [PubMed] [Google Scholar]
  • 32.WHO. Global Physical Activity Questionnaire (GPAQ) Analysis Guide. Geneva World Heal Organ. 2012;1–22.
  • 33.WHO. Global Physical Activity Questionnaire (GPAQ). Surveillance and population-based prevention of non communicable diseases. Department World Health Organization, Geneva, Switzerland. https://www.who.int/ncds/surveillance/steps/GPAQ_EN.pdf.
  • 34.WHO. Physical status: The use and interpretation of anthropometry.Report of a WHO expert committee. 1995;(854, Geneva.). [PubMed]
  • 35.WHO. Body Mass Index—BMI. https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a- healthy-lifestyle/body-mass-index-bmi (accessed on 11 July 2021).
  • 36.Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypert. J Hypertens. 2018;36(10):1953–2041. doi: 10.1097/HJH.000000000000194 [DOI] [PubMed] [Google Scholar]
  • 37.El Kinany K, Garcia-Larsen V, Khalis M, Deoula MMS, Benslimane A, Ibrahim A, et al. Adaptation and validation of a food frequency questionnaire (FFQ) to assess dietary intake in Moroccan adults. Nutr J. 2018;17(1): doi: 10.1186/s12937-018-0368-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.El Ati J, Béji C FA et al. Table de composition des aliments tunisiens. INNTA, Tunis. 2007.
  • 39.J N. Aliments et préparations typiques de la population Marocaine. http://www.ciriha.org/index.php/publications/outils-dietetique/product/7-aliments-et-preparations-typiques-de-la-population-marocaine. Accessed sept 2021.
  • 40.Carlsen M.H., Halvorsen B.L., Holte K et al. The total antioxidant content of more than 3100 foods, beverages, spices, herbs and supplements used worldwide. Nutr J. 2010. doi: 10.1186/1475-2891-9-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Carlsen M., Halvorsen KH B. et al. Additional file 1: the antioxidant food table,. Nutr J. 2010;9. [Google Scholar]
  • 42.Benzie IFF, Strain JJ. Ferric reducing/antioxidant power assay: Direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 1999;299(1995):15–27. doi: 10.1016/s0076-6879(99)99005-5 [DOI] [PubMed] [Google Scholar]
  • 43.Mohamed Mziwira, Mohammed El Ayachi D L and R B. Mediterranean Diet and Metabolic Syndrome in Adult Moroccan Women. J Res Obes. 2015;2015:1–18. doi: 10.5171/2015.896400 [DOI] [Google Scholar]
  • 44.El Achhab Y, Tahraoui A, El-Hilaly J, Lyoussi B. Adherence to a Mediterranean dietary pattern in Moroccan type 2 diabetes patients. Rom J Diabetes, Nutr Metab Dis. 2022;29(1):50–56. doi: 10.46389/rjd-2022-1074 [DOI] [Google Scholar]
  • 45.Lopez-Legarrea P, De La Iglesia R, Abete I, Bondia-Pons I, Navas-Carretero S, Forga L, et al. Short-term role of the dietary total antioxidant capacity in two hypocaloric regimes on obese with metabolic syndrome symptoms: The RESMENA randomized controlled trial. Nutr Metab. 2013;10(1):1. doi: 10.1186/1743-7075-10-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Rahmani J, Parastouei K, Taghdir M, Santos HO, Hosseini Balam F, Saberi Isfeedvajani M. Healthy Eating Index-2015 and Dietary Total Antioxidant Capacity as Predictors of Prediabetes: A Case-Control Study. Int J Endocrinol. 2021;2021:1–7. doi: 10.1155/2021/2742103 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Witkowska AM, Waśkiewicz A, Zujko ME, Szcześniewska D, Pająk A, Stepaniak U, et al. Dietary Polyphenol Intake, but Not the Dietary Total Antioxidant Capacity, Is Inversely Related to Cardiovascular Disease in Postmenopausal Polish Women: Results of WOBASZ and WOBASZ II Studies. Oxid Med Cell Longev. 2017; doi: 10.1155/2017/5982809 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Rossi M, Praud D, Monzio Compagnoni M, Bellocco R, Serafini M, Parpinel M, et al. Dietary non-enzymatic antioxidant capacity and the risk of myocardial infarction: A case-control study in Italy. Nutr Metab Cardiovasc Dis. 2014;24(11):1246–1251. doi: 10.1016/j.numecd.2014.06.007 [DOI] [PubMed] [Google Scholar]
  • 49.Chawla R, Madhu SV, Makkar BM, Ghosh S, Saboo B K S RECG. RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020. Indian J Endocrinol Metab. 2020;24(1):1–122. doi: 10.4103/ijem.IJEM_225_20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Willis HJ S J. The Influence of Diet Interventions Using Whole, Plant Food on the Gut Microbiome: A Narrative Review. J Acad Nutr Diet. 2020;120(4):608–623. doi: 10.1016/j.jand.2019.09.017 [DOI] [PubMed] [Google Scholar]
  • 51.Zujko ME, Waśkiewicz A, Witkowska AM, Cicha-Mikołajczyk A, Zujko K, Drygas W. Dietary Total Antioxidant Capacity—A New Indicator of Healthy Diet Quality in Cardiovascular Diseases: A Polish Cross-Sectional Study. Nutrients. 2022;14(15):. doi: 10.3390/nu14153219 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Cyuńczyk M, Zujko ME, Jamiołkowski J, Zujko K, Łapińska M, Zalewska M, et al. Dietary Total Antioxidant Capacity Is Inversely Associated with Prediabetes and Insulin Resistance in Bialystok PLUS Population. Antioxidants. 2022;11(2): doi: 10.3390/antiox11020283 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Detopoulou P, Panagiotakos DB, Chrysohoou C, Fragopoulou E, Nomikos T, Antonopoulou S, et al. Dietary antioxidant capacity and concentration of adiponectin in apparently healthy adults: The ATTICA study. Eur J Clin Nutr [Internet]. 2010;64(2):161–168. Available from: doi: 10.1038/ejcn.2009.130 [DOI] [PubMed] [Google Scholar]
  • 54.Amiano P, Montes EM, Molinuevo A, Huerta JM, Romaguera D. Association study of dietary non-enzymatic antioxidant capacity (NEAC) and colorectal cancer risk in the Spanish Multicase—Control Cancer (MCC-Spain) study. Eur J Nutr [Internet]. 2018;0(0):0. Available from: doi: 10.1007/s00394-018-1773-3 [DOI] [PubMed] [Google Scholar]
  • 55.Mancini FR, Affret A, Dow C, Balkau B, Bonnet F, Boutron-Ruault MC, et al. Dietary antioxidant capacity and risk of type 2 diabetes in the large prospective E3N-EPIC cohort. Diabetologia. 2018;61(2):308–316. doi: 10.1007/s00125-017-4489-7 [DOI] [PubMed] [Google Scholar]
  • 56.Di Giuseppe R, Arcari A, Serafini M, Di Castelnuovo A, Zito F, De Curtis A, et al. Total dietary antioxidant capacity and lung function in an Italian population: A favorable role in premenopausal/never smoker women. Eur J Clin Nutr. 2012;66(1):61–68. doi: 10.1038/ejcn.2011.148 [DOI] [PubMed] [Google Scholar]
  • 57.Zujko ME, Witkowska AM, Waśkiewicz A, Piotrowski W, Terlikowska KM. Dietary antioxidant capacity of the patients with cardiovascular disease in a cross-sectional study. Nutr J. 2015;14(1):1–13. doi: 10.1186/s12937-015-0005-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.van der Schaft N, Trajanoska K, Rivadeneira F, Ikram MA, Schoufour JD, Voortman T. Total dietary antioxidant capacity and longitudinal trajectories of body composition. Antioxidants. 2020;9(8):1–13. doi: 10.3390/antiox9080728 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Tel Adıgüzel K, Köroğlu Ö, Yaşar E, Kenan Tan A, Samur G. The relationship between dietary total antioxidant capacity, clinical parameters, and oxidative stress in fibromyalgia syndrome: A novel point of view. Turkish J Phys Med Rehabil. 2022;68(2):262–270. doi: 10.5606/tftrd.2022.9741 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Amine EK, Baba NH BM. Diet, nutrition and the prevention of chronic diseases. Geneva: WHO; World Heal Organ Tech Rep Ser 916. 2003. [PubMed]

Decision Letter 0

Charles Odilichukwu R Okpala

10 Dec 2023

PONE-D-23-22322Dietary Total Antioxidant Capacity of subjects with Type 2 Diabetes Mellitus in Northern MoroccoPLOS ONE

Dear Dr. EL FRAKCHI,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:Please kindly check the comments below.

==============================

Please submit your revised manuscript by Jan 21 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Charles Odilichukwu R. Okpala

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Note from Emily Chenette, Editor in Chief of PLOS ONE, and Iain Hrynaszkiewicz, Director of Open Research Solutions at PLOS: Did you know that depositing data in a repository is associated with up to a 25% citation advantage (https://doi.org/10.1371/journal.pone.0230416)? If you’ve not already done so, consider depositing your raw data in a repository to ensure your work is read, appreciated and cited by the largest possible audience. You’ll also earn an Accessible Data icon on your published paper if you deposit your data in any participating repository (https://plos.org/open-science/open-data/#accessible-data).

3. We noticed that this work is related to the following submission of yours currently under review: PONE-D-23-22223 (Association of dietary total antioxidant capacity to general and abdominal obesity in patients with Type 2 Diabetes Mellitus in Northern Morocco.)

Upon submission, authors must confirm that the manuscript, or any related manuscript, is not currently under consideration or accepted elsewhere. If related work has been submitted to PLOS ONE or elsewhere, authors must include a copy with the submitted article (as 'Other' file). Please also discuss the related submission in your cover letter. Reviewers will be asked to comment on the overlap between related submissions (http://journals.plos.org/plosone/s/submission-guidelines#loc-related-manuscripts).

We will carefully review your manuscript upon resubmission, so please ensure that your revision is thorough.

4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 

5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Please, reviewers have found your work very promising, and have provided useful comments.

Kindly attend to them diligently, and provide sufficient details

Look forward to your revised manuscript.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

********** 

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

********** 

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: No

********** 

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscrciprt tilted "Dietary Total Antioxidant Capacity of subjects with Type 2 Diabetes Mellitus in Northern Morocco" is an interesting investigation.

In general, the work was methodical, well written and easy to follow.

However, the authors should consider the following suggestions:

1. Edit to improve the quality of Figure 1 by showing the line axes and also remove the gridlines.

2. Include a section on Conclusion in the Manuscript

3. It would be helpful to have a control (perhaps non diabetic patient) in this investigation to compare.

Reviewer #2: The present manuscript is a good attempt to document the dietary antioxidant intake through validated food frequency questionnaire using the documented international data of FRAP content of foods. The authors should clearly state the primary outcome and secondary outcome of the study. The sampling methodology and the research design needs to be clearly spelt out. The inclusion and exclusion criteria are not stated clearly. The statistical treatment to the antioxidant value data with nutrients and food groups is adequate but it does not states clearly discusses the connect between Dietary Antioxidant intake and Type 2 diabetes.

********** 

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Apr 16;19(4):e0301805. doi: 10.1371/journal.pone.0301805.r002

Author response to Decision Letter 0


2 Feb 2024

Request:

In response to your request, I would like to inform you that I have submitted simultaneously to PLOS ONE journal two original research articles that have been written as an independent paper for publication.

The aforementioned manuscripts were the fruit of a survey carried out on the same clinic population of Moroccan patients with T2DM. Although the same methodology was used for data collection and assessment of dietary intake including dietary TAC assessment, the objective of each manuscript was different.

In PONE-D-23-22322 manuscript, we aimed to bring to light new information about the daily intake of antioxidants among patients with T2DM on the basis of the dietary antioxidant index since it is the first study assessing dietary TAC in Moroccan country. The contribution of common food eaten in Morocco to total antioxidant capacity intake was also examined.

In PONE-D-23-22223 manuscript, we aimed to explore the relationship between dietary TAC of these patients and obesity-related features regarding the importance of obesity in this clinic population as a common comorbidity of type 2 diabetes and one of the most modifiable risk factors for preventing other comorbid conditions, such as cardiovascular disease.

We think so that it is desirable to publish separately the above works and not to present the full data within a single manuscript since each one deals with an objective. Also, that may help to provide more easily understandable information.

We declare that the manuscript is original, has not been published before, and is not currently under consideration or accepted elsewhere.

Reviewer 1:

The quality of Figure 1 was improved as recommended and conclusion section was included as well.

Agreed. Further case-control designed investigation may be considered thereafter.

Reviewer 2:

I carefully rewrite the study design and population section with the intent to meet the aforementioned requirements.

I have also added a short sentence to discuss the connect between Dietary Antioxidant intake and Type 2 diabetes through presented data on dietary intake according to dietary antioxidant capacity.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0301805.s001.docx (16.6KB, docx)

Decision Letter 1

Charles Odilichukwu R Okpala

20 Feb 2024

PONE-D-23-22322R1Dietary Total Antioxidant Capacity of subjects with Type 2 Diabetes Mellitus in Northern MoroccoPLOS ONE

Dear Dr. EL FRAKCHI,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

ACADEMIC EDITOR:Please see comments below.

==============================

Please submit your revised manuscript by Apr 05 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Charles Odilichukwu R. Okpala

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Please, authors kindly attend to the comments raised by a reviewer

You will see that reviewers agree that your work is worthy of publication

The editor also suggests the following:

a) In the introduction, please squeeze in this information, before line 91, and some of it before line 98: 1) The food-health situation of the subregion where Morocco is situated , the foods that dominate the region culturally, the demographics of urban and rural areas within the subregion, and why it is reflective of the dietary situation found in Morrocco

b) Please methods, start this section with new subsection captioned 'Schematic overview of field questionnaire study', which should comprise 4-5 sentences and supported by a flow diagram that shows us how you arranged the entire study. Sentence 1 should introduce the title of flow diagram, Sentence two should talk about the key stages, sentence 3 how it directly connects with the objective of the study, and sentence 4 and 5 show why the study is relevant, why such data analysis was employed, etc. Make sure this new subsection captures all the key stages of the methods

c) I can see you separated your results and discussion. Please, kindly make effort to state (Refer to Table ?) or (Refer to Figure ?) in all the places where tables/figure captured in results and indicated in the discussion. So, all the tables and figure must be captured. Please, make sure to do this, to guide the readers.

d) Please, in your conclusions, provide some recommendations for future work

Look forward to your revised manuscript. Thanks very much :)

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: All the desired and suggested changes are made. One observation in Table 2 about the unit for quantity of food intake especially green tea, black tea, instant coffee in gm per day is not acceptable and other foods consumed preferably should also be defined as number of serving per day which equate to the Total Antioxidant Content in the diet.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Jagmeet Madan

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Apr 16;19(4):e0301805. doi: 10.1371/journal.pone.0301805.r004

Author response to Decision Letter 1


19 Mar 2024

Response to an Additional Editor Comments:

First, I would like to thank you for your consideration of this manuscript.

a) We have added the additional information.

b) The new subsection 'Schematic overview of field questionnaire study' is inserted

c) Rightly, we make the corresponding reference of table and figure in the text

d) Further research is recommended as well

Response to a Request:

In response to your request, I would like to inform you that I have submitted simultaneously to PLOS ONE journal two original research articles that have been written as an independent paper for publication.

The aforementioned manuscripts were the fruit of a survey carried out on the same clinic population of Moroccan patients with T2DM. Although the same methodology was used for data collection and assessment of dietary intake including dietary TAC assessment, the objective of each manuscript was different.

In PONE-D-23-22322 manuscript, we aimed to bring to light new information about the daily intake of antioxidants among patients with T2DM on the basis of the dietary antioxidant index since it is the first study assessing dietary TAC in Moroccan country. The contribution of common food eaten in Morocco to total antioxidant capacity intake was also examined.

In PONE-D-23-22223 manuscript, we aimed to explore the relationship between dietary TAC of these patients and obesity-related features regarding the importance of obesity in this clinic population as a common comorbidity of type 2 diabetes and one of the most modifiable risk factors for preventing other comorbid conditions, such as cardiovascular disease.

We think so that it is desirable to publish separately the above works and not to present the full data within a single manuscript since each one deals with an objective. Also, that may help to provide more easily understandable information.

We declare that the manuscript is original, has not been published before, and is not currently under consideration or accepted elsewhere.

Response to a Reviewer 1:

The quality of Figure 1 was improved as recommended and conclusion section was included as well.

Agreed. Further case-control designed investigation may be considered thereafter.

Response to a Reviewer 2:

I carefully rewrite the study design and population section with the intent to meet the aforementioned requirements.

I have also added a short sentence to discuss the connect between Dietary Antioxidant intake and Type 2 diabetes through presented data on dietary intake according to dietary antioxidant capacity.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0301805.s002.docx (17.9KB, docx)

Decision Letter 2

Charles Odilichukwu R Okpala

24 Mar 2024

Dietary Total Antioxidant Capacity of Moroccan Type 2 Diabetes Mellitus patients

PONE-D-23-22322R2

Dear Dr. EL FRAKCHI,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Charles Odilichukwu R. Okpala

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for revising your work. It is now acceptable for publication.

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: Yes: Jagmeet Madan

**********

Acceptance letter

Charles Odilichukwu R Okpala

2 Apr 2024

PONE-D-23-22322R2

PLOS ONE

Dear Dr. El Frakchi,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Charles Odilichukwu R. Okpala

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0301805.s001.docx (16.6KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0301805.s002.docx (17.9KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES